Evidence-based monitoring protocols for adults aged 30 to 49 using AOD-9604 (HGH fragment 176-191), including labs, dosing schedules, safety parameters, and what to watch for at each stage of therapy.
A clinical review of GHK-Cu copper tripeptide dosing for South Asian patients, covering pharmacogenomics, metabolic risk factors, ethnicity-stratified data, and practical prescribing guidance.
A deep dive into MOTS-c, the mitochondrial-derived peptide first identified in 2015. Covers discovery timeline, mechanism of action, preclinical data, and current research status.
A complete clinical guide to monitoring MOTS-c mitochondrial peptide therapy: which labs to order, when to order them, what values to watch, and how to adjust dosing based on results.
Everything you need to know about traveling with GHK-Cu copper tripeptide peptide therapy: how to store vials in transit, manage airport security, maintain your injection schedule across time zones, and protect skin formulations from heat and humidity.